Celldex Therapeutics, Inc. - Common Stock, par value $0.001 (CLDX)

CUSIP: 15117B202

Q2 2021 13F Holders as of 30 Jun 2021

Holder snapshot 7 signals
Share change
+1,068,826
Put/Call ratio
114%
SEC-reported price per share
$33.44
Number of holders
127
Value change
+$60,325,552
Number of buys
70
Open additional details 1 more signal available
Number of sells
57
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
80,000,000

Security key

15117B202

Report period

Q2 2021

Institutions

127

Top holders

10

Ownership snapshot

Top reported holders of CLDX - Celldex Therapeutics, Inc. - Common Stock, par value $0.001 (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
RTW INVESTMENTS, LP
Disclosed value leader
RTW INVESTMENTS, LP
Comparable rows
15/15
Latest evidence
31 Mar 2021
13F Lead comparable stake: 4.9% Showing 1-6 of 15 holder rows.

Quick read

RTW INVESTMENTS, LP leads the comparable SEC ownership view at 4.9%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens RTW INVESTMENTS, LP's linked filing trail.
Comparable ownership Top 5
RTW INVESTMENTS, LP 4.9%
Redmile Group, LLC 4.2%
EVENTIDE ASSET MANAGEMENT, LLC 2.6%
ADAGE CAPITAL PARTNERS GP, L.L.C. 2.4%
WELLINGTON MANAGEMENT GROUP LLP 2.4%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
RTW INVESTMENTS, LP
13F
Company
13F
4.9%
$80,524,000
3,908,947 shares
31 Mar 2021
Redmile Group, LLC
13F
Company
13F
4.2%
$69,788,000
3,387,788 shares
31 Mar 2021
EVENTIDE ASSET MANAGEMENT, LLC
13F
Company
13F
2.6%
$42,486,000
2,062,433 shares
31 Mar 2021
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
13F
2.4%
$39,140,000
1,900,000 shares
31 Mar 2021
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
13F
2.4%
$38,907,000
1,888,736 shares
31 Mar 2021
STATE STREET CORP
13F
Company
13F
2.3%
$38,666,000
1,876,977 shares
31 Mar 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
127
Shares
35,559,554
Rows available
127
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2021 vs Q1 2021 Across Filers

Q1 2021 holders
109
Q2 2021 holders
127
Holder diff
18
Investor Q1 2021 Shares Q2 2021 Shares Share Diff Share Chg % Q1 2021 value Q2 2021 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .